8-K: HealthLynked Corp. Issues Warrant and Extends Notes in Transaction with CEO's Trust

Sentiment:

Current Report (Form 8-K)


HealthLynked Corp. issued a warrant to purchase 1,353,356 shares and extended the maturity dates of existing notes payable to a trust controlled by its CEO, Dr. Michael Dent.

Capital raiseHealthLynked Corp. issued a convertible promissory note in the principal amount of $420,000 to The Mary S. Dent Gifting Trust.The note is convertible into shares of Company common stock at a conversion price of $0.0375 per share.The Company issued a ten-year warrant to purchase 1,353,356 shares of Common Stock at an exercise price of $0.0375 per share.

Summary

  • HealthLynked Corp. issued a warrant and extended the maturity dates of existing notes in a transaction with The Mary Dent Gifting Trust, controlled by the company's CEO, Dr. Michael Dent.
  • On March 20, 2025, HealthLynked issued a convertible promissory note for $420,000 to the trust, which matures on September 20, 2025, and accrues interest at 12%, increasing to 18% if an event of default remains uncured.
  • The note is convertible into common stock at $0.0375 per share.
  • The company also entered into a Notes Extension Agreement, extending the maturity dates of twelve notes totaling $1,216,500 to September 20, 2025, in exchange for a ten-year warrant to purchase 1,353,356 shares of common stock at an exercise price of $0.0375 per share.
  • The interest rate on the extended notes increased from 12% to 15% after March 20, 2025.
  • The proceeds from the new note will be used for working capital and general corporate purposes.
  • The securities were issued in reliance on an exemption from registration under the Securities Act of 1933.

Sentiment

Score: 5

Explanation: The announcement is neutral. While it provides the company with additional capital, it also increases debt and potential dilution. The related-party aspect adds a layer of complexity.

Positives

  • The transactions provide HealthLynked with additional working capital.
  • Extending the maturity dates of existing notes provides the company with more time to manage its debt obligations.
  • The Holder waived any default under the Notes now occurring or that has occurred, and the Company and Holder acknowledge that the Notes are not in default as of or through the date hereof.

Negatives

  • The transactions increase the company's debt and potential dilution through the issuance of a warrant and convertible note.
  • The increased interest rate on the extended notes will increase the company's interest expense.
  • The transactions involve the CEO's trust, which could raise concerns about conflicts of interest.

Risks

  • The company's ability to repay the debt and manage its working capital.
  • Potential dilution of existing shareholders due to the exercise of the warrant and conversion of the note.
  • The possibility of an event of default, which would trigger a higher interest rate on the new note.
  • The related-party nature of the transaction could raise governance concerns.

Future Outlook

The company intends to use the proceeds from the note for working capital and general corporate purposes.

Industry Context

Small cap companies often use convertible notes and warrants to raise capital, especially when access to traditional financing is limited. Related party transactions are not uncommon but require careful scrutiny to ensure fair terms.

Comparison to Industry Standards

  • The interest rates on the note and extended notes are relatively high, which is typical for small-cap companies with limited access to capital.
  • The use of warrants is a common practice to incentivize investors in high-risk situations.
  • The conversion and exercise prices are low, reflecting the company's current stock price and perceived risk.

Related Party Transactions

  • The Purchaser of the convertible promissory note and the recipient of the warrant is The Mary Dent Gifting Trust, which is controlled by the Chief Executive Officer and Chairman of the Company, Dr. Michael Dent.

Stakeholder Impact

  • Shareholders may experience dilution if the warrant is exercised and the note is converted.
  • The company's financial stability could be affected by the increased debt and interest expense.
  • Employees may be indirectly affected by the company's ability to execute its business plan with the additional capital.

Key Dates

DateDescription
2024Advances totaling $420,000 made by the Mary S. Dent Gifting Trust to HealthLynked Corp.
2024-09Advances made by the Holder to the Company during 2024 as follows: Advance Amount Advance Date Outstanding 09/24/24 $30,000.00 09/30/24 $10,000.00
2024-10Advances made by the Holder to the Company during 2024 as follows: Advance Amount Advance Date Outstanding 10/01/24 $35,000.00 10/08/24 $90,000.00 10/15/24 $60,000.00 10/21/24 $85,000.00
2024-11Advances made by the Holder to the Company during 2024 as follows: Advance Amount Advance Date Outstanding 11/06/24 $70,000.00 11/13/24 $40,000.00
2025-03-20Date of the convertible promissory note, Notes Extension Agreement, and warrant issuance.
2025-03-20Initial Exercise Date of the Common Stock Purchase Warrant
2025-03-26Date of the Current Report on Form 8-K filing.
2025-09-20Maturity date of the convertible promissory note and the extended notes.
2035-03-20Termination Date of the Common Stock Purchase Warrant.

Keywords

warrant, convertible note, notes extension, related party transaction, HealthLynked, debt, financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.